What is the recommended step‑by‑step approach to correct hyperkalemia in an adult patient, including cardiac monitoring, calcium gluconate administration, insulin‑glucose therapy, nebulized albuterol, sodium bicarbonate for acidosis, loop diuretic use, potassium binders, and criteria for emergent dialysis?

Hyperkalemia Correction: Step-by-Step Management

For acute hyperkalemia with ECG changes or potassium >6.0 mEq/L, immediately administer IV calcium gluconate 10 mL of 10% solution to stabilize cardiac membranes, followed by insulin-glucose and nebulized albuterol to shift potassium intracellularly, then initiate potassium removal with diuretics or dialysis based on renal function. 1

Immediate Assessment and Cardiac Monitoring

• Obtain ECG immediately to assess for cardiac toxicity—ECG changes dictate urgency more than absolute potassium values 1, 2
• Classic ECG findings include peaked T waves, widened QRS, prolonged PR interval, and loss of P waves, though absent ECG changes do not exclude the need for urgent treatment 3
• Verify true hyperkalemia by ruling out pseudohyperkalemia from hemolysis, repeated fist clenching, or poor phlebotomy technique 1
• Plasma potassium runs 0.1-0.4 mEq/L lower than serum due to platelet release during coagulation 1

Step 1: Cardiac Membrane Stabilization (Onset: 1-3 minutes)

Administer IV calcium gluconate 10 mL of 10% solution over 2-3 minutes if ECG changes are present or potassium >6.5 mEq/L 1, 2

• Calcium reduces membrane excitation in cardiac tissue without lowering potassium 1
• Do not exceed 200 mg/minute in adults or 100 mg/minute in pediatrics; rapid administration causes hypotension, bradycardia, and arrhythmias 4
• ECG monitoring during administration is mandatory 4
• In cardiac arrest specifically, use calcium chloride 10 mL instead of calcium gluconate for faster action 5
• Avoid or use extreme caution in patients on digoxin—hypercalcemia increases digoxin toxicity and may cause synergistic arrhythmias 4
• Effect lasts 30-60 minutes; may repeat dose if ECG changes persist 2

Step 2: Intracellular Potassium Shift (Onset: 30-60 minutes)

Insulin-Glucose Therapy (First-line)

Administer 10 units regular insulin IV with 50 mL of 50% dextrose (25g glucose) 1, 3

• Lowers potassium by 0.5-1.2 mEq/L for 4-6 hours 2
• Check baseline glucose before administration; if glucose >250 mg/dL, give insulin without dextrose 5
• Monitor glucose at 15,30,60 minutes and hourly for 4-6 hours to detect hypoglycemia 2
• Some experts recommend short-acting synthetic insulins over regular insulin, though evidence is limited 5

Nebulized Albuterol (Adjunctive)

Administer 10-20 mg albuterol via nebulizer over 10 minutes 1, 3

• Stimulates Na+/K+-ATPase to shift potassium intracellularly 1
• Lowers potassium by 0.5-1.0 mEq/L 2
• Effect is short-lived (2-4 hours) and rebound hyperkalemia can occur 1
• Approximately 40% of patients are non-responders to beta-agonists 2
• Additive effect when combined with insulin-glucose 3

Sodium Bicarbonate (Conditional Use)

Administer 50-100 mEq IV over 5-10 minutes ONLY if metabolic acidosis is present 1, 6

• Efficacy as monotherapy is poor and controversial 3
• Promotes intracellular shift and increases urinary potassium excretion when acidosis exists 1
• Avoid in patients with volume overload or heart failure—bicarbonate solutions are hypertonic and increase plasma sodium 6
• Initial dose of 2-5 mEq/kg over 4-8 hours for severe acidosis 6
• Do not attempt full correction in first 24 hours—may cause rebound alkalosis due to delayed ventilatory adjustment 6

Step 3: Potassium Removal from Body

Loop Diuretics (For Non-Oliguric Patients)

Administer furosemide 40-80 mg IV if patient has adequate urine output and residual kidney function 1, 7

• Increases renal potassium excretion 1
• Only effective in non-oliguric patients with preserved renal function 1
• Thiazide diuretics can be added for synergistic effect 7

Potassium Binders

For acute management, consider patiromer or sodium zirconium cyclosilicate (SZC) as they work faster than traditional resins 1, 7, 8

• Patiromer: Start 8.4-16.8 g orally; onset 4-7 hours; lowers potassium by 0.5-1.0 mEq/L 1, 8
• Sodium zirconium cyclosilicate: 10 g orally three times daily; onset 1-2 hours; more rapid than patiromer 1, 8
• Sodium polystyrene sulfonate (SPS) is falling out of favor—associated with intestinal ischemia, colonic necrosis, and 33% mortality rate in some reports 1, 7
• SPS has inconsistent efficacy, variable onset (hours to days), and causes hypocalcemia/hypomagnesemia 1
• Separate binder administration from other oral medications by 3 hours to avoid binding interactions 1

Emergent Hemodialysis Criteria

Initiate emergent dialysis if: 1, 2

• Oliguric or anuric renal failure (urine output <400 mL/day)
• End-stage renal disease (ESRD)
• Refractory hyperkalemia despite medical therapy
• Ongoing potassium release (e.g., tumor lysis syndrome, rhabdomyolysis)
• Severe hyperkalemia (>7.0 mEq/L) with ECG changes unresponsive to initial measures

Hemodialysis is the most efficient method for potassium removal, clearing 25-50 mEq per hour 2, 3

Step 4: Monitoring and Rebound Prevention

• Recheck potassium within 1-2 hours after initial treatment to assess response 1, 2
• Rebound hyperkalemia occurs after 2-4 hours as insulin, albuterol, and bicarbonate effects wear off 1
• Initiate potassium binders early to prevent rebound, even while using temporizing measures 1, 7
• Continue cardiac monitoring until potassium <5.5 mEq/L and ECG normalizes 2

Step 5: Address Underlying Causes

• Review and adjust medications: Do not discontinue RAAS inhibitors (ACEi/ARBs/MRAs) if they improve long-term outcomes—instead, use potassium binders to enable continuation 1, 9
• Discontinuation of RAAS inhibitors in CKD/heart failure increases mortality risk 1
• Identify and remove other culprits: NSAIDs, potassium-sparing diuretics, trimethoprim, heparin 1, 7
• Correct volume depletion if present 10
• Dietary potassium restriction should focus on reducing non-plant sources—evidence for strict restriction is lacking 10

Critical Pitfalls to Avoid

• Never delay calcium administration in severe hyperkalemia waiting for potassium confirmation—treat based on ECG changes 3
• Do not assume normal ECG excludes severe hyperkalemia—atypical or absent ECG changes can occur with life-threatening levels 3
• Avoid calcium in digoxin-toxic patients unless absolutely necessary with continuous ECG monitoring 4
• Do not use sodium bicarbonate as monotherapy—efficacy is poor without acidosis 3
• Avoid sodium polystyrene sulfonate (Kayexalate) due to serious GI adverse effects including bowel necrosis 1, 11
• Monitor for hypoglycemia for at least 4-6 hours after insulin administration 2